Bank of New York Mellon’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $335M | Buy |
|
|||||
|
2021
Q1 | $277M | Sell |
|
|||||
|
2020
Q4 | $300M | Buy |
|
|||||
|
2020
Q3 | $203M | Buy |
|
|||||
|
2020
Q2 | $188M | Buy |
|
|||||
|
2020
Q1 | $149M | Buy |
|
|||||
|
2019
Q4 | $179M | Sell |
|
|||||
|
2019
Q3 | $163M | Buy |
|
|||||
|
2019
Q2 | $213M | Sell |
|
|||||
|
2019
Q1 | $221M | Sell |
|
|||||
|
2018
Q4 | $201M | Sell |
|
|||||
|
2018
Q3 | $368M | Sell |
|
|||||
|
2018
Q2 | $375M | Sell |
|
|||||
|
2018
Q1 | $340M | Sell |
|
|||||
|
2017
Q4 | $372M | Sell |
|
|||||
|
2017
Q3 | $447M | Sell |
|
|||||
|
2017
Q2 | $408M | Buy |
|
|||||
|
2017
Q1 | $398M | Buy |
|
|||||
|
2016
Q4 | $354M | Buy |
|
|||||
|
2016
Q3 | $227M | Sell |
|
|||||
|
2016
Q2 | $217M | Sell |
|
|||||
|
2016
Q1 | $269M | Sell |
|
|||||
|
2015
Q4 | $473M | Sell |
|
|||||
|
2015
Q3 | $412M | Sell |
|
|||||
|
2015
Q2 | $481M | Buy |
|
|||||
|
2015
Q1 | $455M | Sell |
|
|||||
|
2014
Q4 | $520M | Buy |
|
|||||
|
2014
Q3 | $462M | Sell |
|
|||||
|
2014
Q2 | $436M | Buy |
|
|||||
|
2014
Q1 | $395M | Sell |
|
|||||
|
2013
Q4 | $346M | Sell |
|
|||||
|
2013
Q3 | $329M | Sell |
|
|||||
|
2013
Q2 | $265M | Buy |
|